BECN1 and metabolic dysfunction-associated steatotic liver disease: In our study, Beclin1 expression was found to be consistently strong across all experimental groups, suggesting that the initiation of autophagy via Beclin1 is preserved in NAFLD, regardless of the disease stage or quercetin treatment.